Patients and healthcare professionals face new pressures due to changes in the European healthcare landscape — and they are looking to pharma to help them navigate this landscape,
make decisions and manage care.

However, despite interest in pharma content and services, digital assets built to respond to these challenges oftentimes struggle to gain traction.

 

U.S. payers are warming up to covering digital therapeutics

View Now